世界のブドウ膜黒色腫治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Uveal Melanoma Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5009
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、ブドウ膜黒色腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（毛様体黒色腫、虹彩黒色腫、脈絡膜黒色腫）、用途別市場規模（病院、眼科クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・ブドウ膜黒色腫治療の市場動向
・企業の競争状況、市場シェア
・ブドウ膜黒色腫治療の種類別市場規模と予測2016-2027（毛様体黒色腫、虹彩黒色腫、脈絡膜黒色腫）
・ブドウ膜黒色腫治療の用途別市場規模と予測2016-2027（病院、眼科クリニック、その他）
・ブドウ膜黒色腫治療の北米市場規模2016-2027（アメリカ、カナダ）
・ブドウ膜黒色腫治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・ブドウ膜黒色腫治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・ブドウ膜黒色腫治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・ブドウ膜黒色腫治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Eli Lilly & Co.、Spectrum Pharmaceuticals, Inc.、Novartis AG、Bayer、Astra Zeneca plc、Merck、Amgen、Pfizer, Inc.、Roche）
・結論

Uvea is found in the back of the sclera and the cornea and has three parts: the iris, the ciliary body and the choroid. Uveal melanoma, including the iris choroid and cilira body, is referred to as cancer of the areas of the skin. This is the state in which the tumors emerge from the melanocytes that are responsible for the color of the eye inside the uva.
It is the most common form of intraocular malignancy in adults, although it is an uncommon disorder. The treatment of uveal melanoma depends on the size of the tumor, which is the most significant factor. In the early stages, this kind of melanoma is completely asymptomatic. Some modifications can be observed in tumor enlargement over time, such as pupil distortion, reduced visibility due to blurred vision, and secondary retinal detachment.

Market Analysis and Insights: Global Uveal Melanoma Treatment Market
The global Uveal Melanoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Uveal Melanoma Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Uveal Melanoma Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Uveal Melanoma Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Uveal Melanoma Treatment market.

Global Uveal Melanoma Treatment Scope and Market Size
Uveal Melanoma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Uveal Melanoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Ciliary Melanoma
Iris Melanoma
Choroid Melanoma

Segment by Application
Hospitals
Ophthalmology Clinics
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Eli Lilly & Co.
Spectrum Pharmaceuticals, Inc.
Novartis AG
Bayer
Astra Zeneca plc
Merck
Amgen
Pfizer, Inc.
Roche

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Uveal Melanoma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Ciliary Melanoma
1.2.3 Iris Melanoma
1.2.4 Choroid Melanoma
1.3 Market by Application
1.3.1 Global Uveal Melanoma Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ophthalmology Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Uveal Melanoma Treatment Market Perspective (2016-2027)
2.2 Uveal Melanoma Treatment Growth Trends by Regions
2.2.1 Uveal Melanoma Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Uveal Melanoma Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Uveal Melanoma Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Uveal Melanoma Treatment Industry Dynamic
2.3.1 Uveal Melanoma Treatment Market Trends
2.3.2 Uveal Melanoma Treatment Market Drivers
2.3.3 Uveal Melanoma Treatment Market Challenges
2.3.4 Uveal Melanoma Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Uveal Melanoma Treatment Players by Revenue
3.1.1 Global Top Uveal Melanoma Treatment Players by Revenue (2016-2021)
3.1.2 Global Uveal Melanoma Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Uveal Melanoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Uveal Melanoma Treatment Revenue
3.4 Global Uveal Melanoma Treatment Market Concentration Ratio
3.4.1 Global Uveal Melanoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Uveal Melanoma Treatment Revenue in 2020
3.5 Uveal Melanoma Treatment Key Players Head office and Area Served
3.6 Key Players Uveal Melanoma Treatment Product Solution and Service
3.7 Date of Enter into Uveal Melanoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Uveal Melanoma Treatment Breakdown Data by Type
4.1 Global Uveal Melanoma Treatment Historic Market Size by Type (2016-2021)
4.2 Global Uveal Melanoma Treatment Forecasted Market Size by Type (2022-2027)

5 Uveal Melanoma Treatment Breakdown Data by Application
5.1 Global Uveal Melanoma Treatment Historic Market Size by Application (2016-2021)
5.2 Global Uveal Melanoma Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Uveal Melanoma Treatment Market Size (2016-2027)
6.2 North America Uveal Melanoma Treatment Market Size by Type
6.2.1 North America Uveal Melanoma Treatment Market Size by Type (2016-2021)
6.2.2 North America Uveal Melanoma Treatment Market Size by Type (2022-2027)
6.2.3 North America Uveal Melanoma Treatment Market Size by Type (2016-2027)
6.3 North America Uveal Melanoma Treatment Market Size by Application
6.3.1 North America Uveal Melanoma Treatment Market Size by Application (2016-2021)
6.3.2 North America Uveal Melanoma Treatment Market Size by Application (2022-2027)
6.3.3 North America Uveal Melanoma Treatment Market Size by Application (2016-2027)
6.4 North America Uveal Melanoma Treatment Market Size by Country
6.4.1 North America Uveal Melanoma Treatment Market Size by Country (2016-2021)
6.4.2 North America Uveal Melanoma Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Uveal Melanoma Treatment Market Size (2016-2027)
7.2 Europe Uveal Melanoma Treatment Market Size by Type
7.2.1 Europe Uveal Melanoma Treatment Market Size by Type (2016-2021)
7.2.2 Europe Uveal Melanoma Treatment Market Size by Type (2022-2027)
7.2.3 Europe Uveal Melanoma Treatment Market Size by Type (2016-2027)
7.3 Europe Uveal Melanoma Treatment Market Size by Application
7.3.1 Europe Uveal Melanoma Treatment Market Size by Application (2016-2021)
7.3.2 Europe Uveal Melanoma Treatment Market Size by Application (2022-2027)
7.3.3 Europe Uveal Melanoma Treatment Market Size by Application (2016-2027)
7.4 Europe Uveal Melanoma Treatment Market Size by Country
7.4.1 Europe Uveal Melanoma Treatment Market Size by Country (2016-2021)
7.4.2 Europe Uveal Melanoma Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Uveal Melanoma Treatment Market Size (2016-2027)
8.2 Asia-Pacific Uveal Melanoma Treatment Market Size by Type
8.2.1 Asia-Pacific Uveal Melanoma Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Uveal Melanoma Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Uveal Melanoma Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Uveal Melanoma Treatment Market Size by Application
8.3.1 Asia-Pacific Uveal Melanoma Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Uveal Melanoma Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Uveal Melanoma Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Uveal Melanoma Treatment Market Size by Region
8.4.1 Asia-Pacific Uveal Melanoma Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Uveal Melanoma Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Uveal Melanoma Treatment Market Size (2016-2027)
9.2 Latin America Uveal Melanoma Treatment Market Size by Type
9.2.1 Latin America Uveal Melanoma Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Uveal Melanoma Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Uveal Melanoma Treatment Market Size by Type (2016-2027)
9.3 Latin America Uveal Melanoma Treatment Market Size by Application
9.3.1 Latin America Uveal Melanoma Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Uveal Melanoma Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Uveal Melanoma Treatment Market Size by Application (2016-2027)
9.4 Latin America Uveal Melanoma Treatment Market Size by Country
9.4.1 Latin America Uveal Melanoma Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Uveal Melanoma Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Uveal Melanoma Treatment Market Size (2016-2027)
10.2 Middle East & Africa Uveal Melanoma Treatment Market Size by Type
10.2.1 Middle East & Africa Uveal Melanoma Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Uveal Melanoma Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Uveal Melanoma Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Uveal Melanoma Treatment Market Size by Application
10.3.1 Middle East & Africa Uveal Melanoma Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Uveal Melanoma Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Uveal Melanoma Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Uveal Melanoma Treatment Market Size by Country
10.4.1 Middle East & Africa Uveal Melanoma Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Uveal Melanoma Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Eli Lilly & Co.
11.1.1 Eli Lilly & Co. Company Details
11.1.2 Eli Lilly & Co. Business Overview
11.1.3 Eli Lilly & Co. Uveal Melanoma Treatment Introduction
11.1.4 Eli Lilly & Co. Revenue in Uveal Melanoma Treatment Business (2016-2021)
11.1.5 Eli Lilly & Co. Recent Development
11.2 Spectrum Pharmaceuticals, Inc.
11.2.1 Spectrum Pharmaceuticals, Inc. Company Details
11.2.2 Spectrum Pharmaceuticals, Inc. Business Overview
11.2.3 Spectrum Pharmaceuticals, Inc. Uveal Melanoma Treatment Introduction
11.2.4 Spectrum Pharmaceuticals, Inc. Revenue in Uveal Melanoma Treatment Business (2016-2021)
11.2.5 Spectrum Pharmaceuticals, Inc. Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Uveal Melanoma Treatment Introduction
11.3.4 Novartis AG Revenue in Uveal Melanoma Treatment Business (2016-2021)
11.3.5 Novartis AG Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Uveal Melanoma Treatment Introduction
11.4.4 Bayer Revenue in Uveal Melanoma Treatment Business (2016-2021)
11.4.5 Bayer Recent Development
11.5 Astra Zeneca plc
11.5.1 Astra Zeneca plc Company Details
11.5.2 Astra Zeneca plc Business Overview
11.5.3 Astra Zeneca plc Uveal Melanoma Treatment Introduction
11.5.4 Astra Zeneca plc Revenue in Uveal Melanoma Treatment Business (2016-2021)
11.5.5 Astra Zeneca plc Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Uveal Melanoma Treatment Introduction
11.6.4 Merck Revenue in Uveal Melanoma Treatment Business (2016-2021)
11.6.5 Merck Recent Development
11.7 Amgen
11.7.1 Amgen Company Details
11.7.2 Amgen Business Overview
11.7.3 Amgen Uveal Melanoma Treatment Introduction
11.7.4 Amgen Revenue in Uveal Melanoma Treatment Business (2016-2021)
11.7.5 Amgen Recent Development
11.8 Pfizer, Inc.
11.8.1 Pfizer, Inc. Company Details
11.8.2 Pfizer, Inc. Business Overview
11.8.3 Pfizer, Inc. Uveal Melanoma Treatment Introduction
11.8.4 Pfizer, Inc. Revenue in Uveal Melanoma Treatment Business (2016-2021)
11.8.5 Pfizer, Inc. Recent Development
11.9 Roche
11.9.1 Roche Company Details
11.9.2 Roche Business Overview
11.9.3 Roche Uveal Melanoma Treatment Introduction
11.9.4 Roche Revenue in Uveal Melanoma Treatment Business (2016-2021)
11.9.5 Roche Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Uveal Melanoma Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Ciliary Melanoma
Table 3. Key Players of Iris Melanoma
Table 4. Key Players of Choroid Melanoma
Table 5. Global Uveal Melanoma Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Uveal Melanoma Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Uveal Melanoma Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Uveal Melanoma Treatment Market Share by Regions (2016-2021)
Table 9. Global Uveal Melanoma Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Uveal Melanoma Treatment Market Share by Regions (2022-2027)
Table 11. Uveal Melanoma Treatment Market Trends
Table 12. Uveal Melanoma Treatment Market Drivers
Table 13. Uveal Melanoma Treatment Market Challenges
Table 14. Uveal Melanoma Treatment Market Restraints
Table 15. Global Uveal Melanoma Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Uveal Melanoma Treatment Market Share by Players (2016-2021)
Table 17. Global Top Uveal Melanoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Uveal Melanoma Treatment as of 2020)
Table 18. Ranking of Global Top Uveal Melanoma Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Uveal Melanoma Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Uveal Melanoma Treatment Product Solution and Service
Table 22. Date of Enter into Uveal Melanoma Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Uveal Melanoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Uveal Melanoma Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Uveal Melanoma Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Uveal Melanoma Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Uveal Melanoma Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Uveal Melanoma Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Uveal Melanoma Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Uveal Melanoma Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Uveal Melanoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Uveal Melanoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Uveal Melanoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Uveal Melanoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Uveal Melanoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Uveal Melanoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Uveal Melanoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Uveal Melanoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Uveal Melanoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Uveal Melanoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Uveal Melanoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Uveal Melanoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Uveal Melanoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Uveal Melanoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Uveal Melanoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Uveal Melanoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Uveal Melanoma Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Uveal Melanoma Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Uveal Melanoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Uveal Melanoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Uveal Melanoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Uveal Melanoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Uveal Melanoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Uveal Melanoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Uveal Melanoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Uveal Melanoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Uveal Melanoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Uveal Melanoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Uveal Melanoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Uveal Melanoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Eli Lilly & Co. Company Details
Table 63. Eli Lilly & Co. Business Overview
Table 64. Eli Lilly & Co. Uveal Melanoma Treatment Product
Table 65. Eli Lilly & Co. Revenue in Uveal Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 66. Eli Lilly & Co. Recent Development
Table 67. Spectrum Pharmaceuticals, Inc. Company Details
Table 68. Spectrum Pharmaceuticals, Inc. Business Overview
Table 69. Spectrum Pharmaceuticals, Inc. Uveal Melanoma Treatment Product
Table 70. Spectrum Pharmaceuticals, Inc. Revenue in Uveal Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 71. Spectrum Pharmaceuticals, Inc. Recent Development
Table 72. Novartis AG Company Details
Table 73. Novartis AG Business Overview
Table 74. Novartis AG Uveal Melanoma Treatment Product
Table 75. Novartis AG Revenue in Uveal Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 76. Novartis AG Recent Development
Table 77. Bayer Company Details
Table 78. Bayer Business Overview
Table 79. Bayer Uveal Melanoma Treatment Product
Table 80. Bayer Revenue in Uveal Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 81. Bayer Recent Development
Table 82. Astra Zeneca plc Company Details
Table 83. Astra Zeneca plc Business Overview
Table 84. Astra Zeneca plc Uveal Melanoma Treatment Product
Table 85. Astra Zeneca plc Revenue in Uveal Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 86. Astra Zeneca plc Recent Development
Table 87. Merck Company Details
Table 88. Merck Business Overview
Table 89. Merck Uveal Melanoma Treatment Product
Table 90. Merck Revenue in Uveal Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 91. Merck Recent Development
Table 92. Amgen Company Details
Table 93. Amgen Business Overview
Table 94. Amgen Uveal Melanoma Treatment Product
Table 95. Amgen Revenue in Uveal Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 96. Amgen Recent Development
Table 97. Pfizer, Inc. Company Details
Table 98. Pfizer, Inc. Business Overview
Table 99. Pfizer, Inc. Revenue in Uveal Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 100. Pfizer, Inc. Recent Development
Table 101. Roche Company Details
Table 102. Roche Business Overview
Table 103. Roche Uveal Melanoma Treatment Product
Table 104. Roche Revenue in Uveal Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 105. Roche Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Uveal Melanoma Treatment Market Share by Type: 2020 VS 2027
Figure 2. Ciliary Melanoma Features
Figure 3. Iris Melanoma Features
Figure 4. Choroid Melanoma Features
Figure 5. Global Uveal Melanoma Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Ophthalmology Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Uveal Melanoma Treatment Report Years Considered
Figure 10. Global Uveal Melanoma Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Uveal Melanoma Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Uveal Melanoma Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Uveal Melanoma Treatment Market Share by Regions (2022-2027)
Figure 14. Global Uveal Melanoma Treatment Market Share by Players in 2020
Figure 15. Global Top Uveal Melanoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Uveal Melanoma Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Uveal Melanoma Treatment Revenue in 2020
Figure 17. Global Uveal Melanoma Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Uveal Melanoma Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Uveal Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Uveal Melanoma Treatment Market Share by Type (2016-2027)
Figure 21. North America Uveal Melanoma Treatment Market Share by Application (2016-2027)
Figure 22. North America Uveal Melanoma Treatment Market Share by Country (2016-2027)
Figure 23. United States Uveal Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Uveal Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Uveal Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Uveal Melanoma Treatment Market Share by Type (2016-2027)
Figure 27. Europe Uveal Melanoma Treatment Market Share by Application (2016-2027)
Figure 28. Europe Uveal Melanoma Treatment Market Share by Country (2016-2027)
Figure 29. Germany Uveal Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Uveal Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Uveal Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Uveal Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Uveal Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Uveal Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Uveal Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Uveal Melanoma Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Uveal Melanoma Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Uveal Melanoma Treatment Market Share by Region (2016-2027)
Figure 39. China Uveal Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Uveal Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Uveal Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Uveal Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Uveal Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Uveal Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Uveal Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Uveal Melanoma Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Uveal Melanoma Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Uveal Melanoma Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Uveal Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Uveal Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Uveal Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Uveal Melanoma Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Uveal Melanoma Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Uveal Melanoma Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Uveal Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Uveal Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Uveal Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Eli Lilly & Co. Revenue Growth Rate in Uveal Melanoma Treatment Business (2016-2021)
Figure 59. Spectrum Pharmaceuticals, Inc. Revenue Growth Rate in Uveal Melanoma Treatment Business (2016-2021)
Figure 60. Novartis AG Revenue Growth Rate in Uveal Melanoma Treatment Business (2016-2021)
Figure 61. Bayer Revenue Growth Rate in Uveal Melanoma Treatment Business (2016-2021)
Figure 62. Astra Zeneca plc Revenue Growth Rate in Uveal Melanoma Treatment Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Uveal Melanoma Treatment Business (2016-2021)
Figure 64. Amgen Revenue Growth Rate in Uveal Melanoma Treatment Business (2016-2021)
Figure 65. Pfizer, Inc. Revenue Growth Rate in Uveal Melanoma Treatment Business (2016-2021)
Figure 66. Roche Revenue Growth Rate in Uveal Melanoma Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

Global Metastatic Uveal Melanoma Thereapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5859 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、転移性ブドウ膜メラノーマ治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（リンゴ酸スニチニブ、硫酸ビンクリスチンリポソーム、LY-2801653、酢酸ソトラスタウリン、その他）、用途別市場規模（病...

世界の転移性黒色腫治療市場規模・現状・予測（2021年-2027年）

Global Metastatic Melanoma Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4498 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、転移性黒色腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（標的化学療法、標的免疫療法、標的MAPキナーゼ療法、抗血管新生療法、その他）、用途別市場規模（病院、クリニック、外来手術センター、その他...

世界の悪性黒色腫治療市場規模・現状・予測（2021年-2027年）

Global Malignant Melanoma Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4459 2021年6月 128Pages
QYResearch社発行の本調査レポートでは、悪性黒色腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（外科療法、放射線療法、化学療法、生物学的療法/標的療法）、用途別市場規模（病院、クリニック、外来手術センター、その他）、主要地域別市場規模...

世界の黒色腫検出市場規模・現状・予測（2021年-2027年）

Global Melanoma Detection Market Size, Status and Forecast 2021-2027
QFJ1-4486 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、黒色腫検出の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（生検、画像、その他）、用途別市場規模（病院、スキンケアクリニック、診断センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界の黒色腫分子診断市場規模・現状・予測（2021年-2027年）

Global Melanoma Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4488 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、黒色腫分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、ア...

世界の悪性黒子型黒色腫治療市場規模・現状・予測（2021年-2027年）

Global Lentigo Maligna Melanoma Therapeutic Market Size, Status and Forecast 2021-2027
QFJ1-5830 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、悪性黒子型黒色腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、免疫療法、標的療法、放射線療法）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の黒色腫診断＆治療薬市場規模・現状・予測（2021年-2027年）

Global Melanoma Diagnostics and Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4487 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、黒色腫診断＆治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（結節型黒色腫、表在性黒色腫、無色素性黒色腫、その他）、用途別市場規模（病院、診断センター、医療機関、その他）、主要地域別市場規模（北米...

世界の転移性悪性黒色腫治療市場規模・現状・予測（2021年-2027年）

Global Metastatic Malignant Melanoma Therapy Market Size, Status and Forecast 2021-2027
QFJ1-5857 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、転移性悪性黒色腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（免疫療法、標的療法、その他）、用途別市場規模（病院、医療研究機関、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の転移性ブドウ膜メラノーマ治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Metastatic Uveal Melanoma Thereapeutics Market The global Metastatic Uveal Melanoma Thereapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis…
世界の転移性黒色腫治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Metastatic Melanoma Treatment Market The global Metastatic Melanoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integ…
世界の悪性黒色腫治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Malignant Melanoma Treatment Market The global Malignant Melanoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integri…
世界の黒色腫検出市場規模・現状・予測（2021年-2027年） Melanoma is a type of skin cancer where melanocytes lose its ability of apoptosis. Melanoma can develop anywhere on the epidermis, but most probably it affects trunk and legs of the body. North America dominates the global Melanoma detection Market due to the high prevalence among the patient popula…
世界の黒色腫分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing melanoma Market Analysis and Insights: Global Melanoma Molecular Diagnostics Market The global Melanoma Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-st…